advertisement

Editors Selection IGR 14-3

List of Editor's Selection comments by

Horacio Uri Saragovi
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada

• Experimental Glaucoma: Neuroprotection (14-3, April 2013) on:
  50979 Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma
  Roh M; Zhang Y; Murakami Y et al.
  PLoS ONE 2012; 7: e40065

  ---